News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
FDA
EU Approves Novartis Corporation’s Eucreas Diabetes Drug
February 25, 2008
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
ZURICH, Feb 25 (Reuters) - The European Union approved Novartis's Eucreas diabetes pill, the Swiss drugmaker said on Monday, following its approval of Galvus, one of the two-in-one drug's ingredients.
Twitter
LinkedIn
Facebook
Email
Print
FDA
Approvals
Europe
MORE ON THIS TOPIC
ADCs
Patient Deaths Put Merck, Daiichi Sankyo’s Antibody-Drug Conjugate on Hold
December 19, 2025
·
2 min read
·
Tristan Manalac
Obesity
Novo Nordisk Files Combo Obesity Drug CagriSema For FDA Approval
December 18, 2025
·
2 min read
·
Dan Samorodnitsky
Regulatory
FDA Mulls National Priority Vouchers for Two Potential Merck Blockbusters: Report
December 18, 2025
·
2 min read
·
Tristan Manalac
Approvals
GSK Wins Asthma Approval for Anti-Inflammatory Antibody
December 17, 2025
·
2 min read
·
Tristan Manalac
